3) renal ischemia reperfusion injury
肾脏缺血再灌注损伤
1.
Objective: To observe the influence of Astragalus injection on the apoptosis of cells in rats after renal ischemia reperfusion injury in order to elucidate the mechanism of its protective effect.
目的:观察黄芪注射液对大鼠肾脏缺血再灌注细胞凋亡的影响,探讨其对肾脏缺血再灌注损伤的保护机制。
2.
Conclusion: The adhesion of neutrophil to kidney and the activation of free radicals could be mediated by MMP-2,and VitC may alleviate renal ischemia reperfusion injury through decreasing the expression of MMP-2.
结论:肾脏缺血再灌注时,MMP-2参与介导了中性粒细胞对肾组织的浸润和自由基的活化,VitC可能通过降低MMP-2在肾组织中的表达而减轻肾脏缺血再灌注损伤。
4) hepatic ischemia reperfusion
肝脏缺血再灌注
1.
Protection of heme oxygenase-1 against hepatic ischemia reperfusion injury in cirrhotic rats;
血红素氧合酶-1对肝硬化大鼠肝脏缺血再灌注损伤的保护作用
2.
Objective: To investigate the protective role and mechanism of L-arginine in hepatic ischemia reperfusion injury.
目的 :探讨右旋精氨酸 (L(+) -arginine·[a]D2 0 +15 5 ,L -arginine)对肝脏缺血再灌注损伤的保护作用及其作用机制。
3.
IntroductionHepatic ischemia reperfusion(HIR) is one of important factors to cause hepatic injury during hepatic transplantation and hepatic surgery procedure.
前言 在肝脏移植和肝脏外科手术中,肝脏缺血再灌注(hepatic ischemia reperfusion,HIR)是引起肝脏损伤的一个重要因素。
6) Hepatic ischemia-reperfusion
肝脏缺血再灌注
1.
Effect of Anisodamine on Nuclear Factor-kappa B in Rats with Hepatic Ischemia-reperfusion Injury;
目的 探讨NF-κB在大鼠肝脏缺血再灌注损伤中的表达和山莨菪碱的保护作用。
补充资料:离体肝脏血流灌注
离体肝脏血流灌注
extracorporeal hepatic perfusion
见“体外肝脏灌注”。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条